Herly, M. http://orcid.org/0000-0002-3100-0850
Stengaard-Pedersen, K. http://orcid.org/0000-0003-0779-8054
Vestergaard, P. http://orcid.org/0000-0002-9046-2967
Christensen, R. http://orcid.org/0000-0002-6600-0631
Möller, S. http://orcid.org/0000-0003-0858-4269
Østergaard, M. http://orcid.org/0000-0003-3690-467X
Junker, P. http://orcid.org/0000-0002-2684-9964
Hetland, M. L. http://orcid.org/0000-0003-4229-6818
Hørslev-Petersen, K. http://orcid.org/0000-0002-5475-7610
Ellingsen, T. http://orcid.org/0000-0003-0426-4962
Article History
Received: 24 June 2019
Accepted: 9 April 2020
First Online: 30 April 2020
Competing interests
: Dr. Herly reports grants from Pfizer Denmark, during the conduct of the study; personal fees from Danish Rheumatism Association, outside the submitted work. Dr. Christensen reports non-financial support from Board membership, grants from Consultancy (AbbVie, Amgen, Axellus A/S, Biogen, Bristol-Myers Squibb, Cambridge Weight Plan, Celgene, Eli Lilly, Hospira, MSD, Norpharma, Novartis, Orkla Health, Pfizer, Roche, Sobi, Takeda), personal fees from Employment (Research Unit for Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark), non-financial support from Expert testimony, grants from Grants/grants pending (Axellus A/S, AbbVie, Cambridge Weight Plan, Janssen, MSD, Mundipharma, Novartis, and Roche), grants from Payment for lectures including service on speakers bureaus (Abbott, Amgen, Axellus, Bayer HealthCare Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Cambridge Weight Plan, Ipsen, Janssen, Laboratoires Expanscience, MSD, Mundipharma, Norpharma, Novartis, Pfizer, Roche, Rottapharm-Madaus, Sobi, and Wyeth), grants from Payment for manuscript preparation (Axellus, Bristol-Myers Squibb, and Cambridge Weight Plan, Aleris-Hamlet (via Norpharma)), non-financial support from Patents (planned, pending or issued), non-financial support from Royalties, grants from Payment for development of educational presentations (Bristol-Myers Squibb, MSD, Pfizer), non-financial support from Stock/stock options, grants from Travel/accommodations/meeting expenses unrelated to activities listed (Abbott, AbbVie, Axellus, Biogen, Bristol-Myers Squibb, Cambridge Weight Plan, Celgene, Laboratoires Expanscience, Norpharma, Novartis, Pfizer, Roche, Rottapharm-Madaus, and Wyeth), non-financial support from Other (err on the side of full disclosure), outside the submitted work; and I am involved in many health-care initiatives and research that could benefit from wide uptake of this publication (including Cochrane, OMERACT, IDEOM, RADS, and the GRADE Working Group). Musculoskeletal Statistics Unit, The Parker Institute is grateful for the financial support received from public and private foundations, companies and private individuals over the years. The Parker Institute is supported by a core grant from the Oak Foundation (OCAY-18–774-OFIL); The Oak Foundation is a group of philanthropic organizations that, since its establishment in 1983, has given grants to not-for-profit organizations around the world. Dr. Østergaard reports grants, personal fees and non-financial support from AbbVie, grants, personal fees and non-financial support from BMS, personal fees from Boehringer-Ingelheim, personal fees from Eli Lilly, personal fees and non-financial support from Janssen, grants, personal fees and non-financial support from Merck, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Roche, grants, personal fees and non-financial support from UCB, grants and personal fees from Celgene, personal fees from Sanofi, personal fees from Regeneron, grants, personal fees and non-financial support from Novartis, personal fees from Orion, personal fees from Hospira, outside the submitted work. Dr. Hetland reports grants from AbbVie, grants from Biogen, grants from BMS, personal fees from CellTrion, grants from MSD, grants from Novartis, personal fees from Orion, grants from Pfizer, personal fees from Samsung, grants from UCB, outside the submitted work. Dr. Hørslev-Petersen reports grants from travel expences (eular 2018, pfizer), outside the submitted work;. Dr. Stengaard-Pedersen, Dr. Vestergaard, Dr. Möller, Dr. Junker and Dr. Ellingsen have nothing to disclose.